84.88
-2.75%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Micro-Tech Nanjing Co
Its shares trade on Shanghai under the ticker 688029.SS. It has been listed since 22 July 2019. In the fiscal year to 31 December 2025, it reported revenue of CN¥3.19bn and net income of CN¥570.1m. At that date it held total assets of CN¥5.46bn and shareholders' equity of CN¥4.24bn.
Micro-Tech (Nanjing) Co., Ltd. engages in the manufacture of medical equipment. The company is headquartered in Nanjing, Jiangsu. The company went IPO on 2019-07-22. The firm's main products include three series of endoscopic diagnosis and treatment instruments used with endoscopes, microwave ablation equipment and consumables, and disposable endoscopes. Endoscopic diagnosis and treatment equipment mainly includes biopsy, hemostasis and closure, Endoscopic Mucosal Resection (EMR)/Endoscopic Submucosal Dissection (ESD), dilation, and Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasonography (EUS) and Endobronchial Ultrasound (EBUS) products. Microwave ablation mainly includes microwave ablation instrument and microwave ablation needle series products. Disposable endoscope mainly includes disposable biliopancreatic imaging system (choledochoscope) and related consumables and other products.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 22 Jul 2019
- Employees
- 2,383
- Website
- micro-tech.com.cn ↗
Leadership
Pay as last reported
- Mr. Xiaohui LongChairman of the Board, since 2015CN¥4.9m
- Mr. Derong LengPresident, Director, since 2015CN¥4.9m
- Mr. Changqing LiExecutive President, Director, since 2015CN¥4.5m
- Mr. Chenwei RuiFinance Director, Senior Vice PresidentCN¥2.7m
- Mr. Bo ZhangSenior Vice President, Director, since 2016CN¥3.9m
- Mr. Georg HarkSenior Vice PresidentCN¥2.7m
- Mr. Daniel KuhnSenior Vice PresidentCN¥2.7m
- Mr. Feng ZhangSenior Vice PresidentCN¥3.9m
- Mr. Jiefeng XiChief Scientific OfficerCN¥2.8m
- Mr. Xingliang GongVice President, Secretary of the Board, Senior Chief Legal Affairs OfficerCN¥2.2m
- Mr. Chunjun LiuVice President, Senior Chief Administration and Government Affairs OfficerCN¥2.2m
- Ms. Ning LiChief Quality Regulatory OfficerCN¥1.8m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 68
- Environment
- 99
- Social
- 75
- Governance
- 30
- Direct emissions (scope 1)
- 401.56 t
- Energy emissions (scope 2)
- 8,834.58 t
- Value chain emissions (scope 3)
- 55,450.73 t
- Women in the workforce
- 62.66234%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company employs 2383 full-time employees.
- Offers three series of endoscopic diagnosis and treatment instruments.
- Produces microwave ablation equipment and consumables.
Weaknesses
- No specific weaknesses mentioned in the provided information.
- No information on financial performance or market share provided.
- No details on competitive advantages or unique technologies.
Opportunities
- Expansion of endoscopic diagnosis and treatment equipment market.
- Growth potential in microwave ablation equipment sector.
- Increasing demand for disposable endoscopes in medical procedures.
Threats
- Competition from other medical equipment manufacturers.
- Regulatory changes in the health care industry.
- Potential supply chain disruptions affecting production.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.